VEC.L Share News (VEC)

Vectura Partner Sandoz Receives Swedish Okay For Asthma Inhaler

LONDON (Alliance News) - Vectura Group PLC said Tuesday that its partner Sandoz has received marketing authorisation for its AirFluSal Forspira inhaler in Sweden. The authorisation comes just a day after AirFluSal Forspira received marketing authorisation in Germany. The AirFluSal inh

Generic version of GSK's Advair approved by Germany

LONDON, Jan 13 (Reuters) - Germany approved the sale of a generic version of GlaxoSmithKline's Advair on Monday, becoming the second country in Europe to authorise a copy of the top-selling inhaled lung drug. Britain's Vectura said its partner Sandoz, the generics division of Switzerland's

Thursday broker round-up UPDATE

AstraZeneca: Alphavalue lowers target price from 3169p to 3087.7p and downgrades from reduce to sell. British American Tabacco: Panmure Gordon reduces target price from 3800p to 3200p and downgrades from buy to hold. Britvic: Investec ups target price from 600p to 672p and maintains a hold recomme

Glaxo COPD approval cooled by generic Advair competition

US regulators have approved GlaxoSmithKline's treatment for chronic obstructive pulmonary disease, but the excitement was cooled by news that Denmark has approved the sale of a generic copy of GSK's biggest product, Advair. On Wednesday evening Glaxo and Theravance announced that the US Food and Dr

REFILE-UPDATE 3-Denmark approves generic copy of GSK's top-selling lung drug

(Refiled to improve headline, no change to text) * Green light generic copy of GSK's $8-billion drug Advair * Danish approval is first for product in Europe * Inhaled medicine developed by Vectura and Sandoz * News overshadows U.S. approval for new GSK drug Anoro * G

STOCKS NEWS EUROPE-UK small caps close up 0.6 pct

The FTSE small cap index closes 0.6 percent higher, beating gains of 0.1 percent on both the blue-chip FTSE 100 index and the FTSE 250 mid-cap index. Electrical retailer Darty rises 3.4 percent after the company posts higher first-half profits and says it has agreed to sell its Turkish busi

Vectura/Sandoz lung drug, seen as generic Advair, approved in Denmark

LONDON, Dec 18 (Reuters) - Vectura said its partner Sandoz had received Danish approval for an inhaled lung drug that analysts widely believe to be a generic version of GlaxoSmithKline's $8 billion-a-year blockbuster Advair. British pharmaceutical company Vectura said in a statement on Wedn

UK BROKER RATING CHANGES: Barclays Initiates Housebuilders

Vectura Widens Pretax Loss On Increased Research And Development Expenses

Vectura, UCB To Collaborate To Develop Biologic Immunomodulatory Product

Tuesday broker round-up UPDATE

African Barrick Gold: Liberum Capital upgrades to hold with a target price of 147p. Amec: UBS reduces target price from 1200p to 1145p downgrading from buy to neutral. Compass Group: Investec ups target price from 900p to 925p and keeps a buy recommendation. CVS Group: Investec takes target price

Broker Rating Changes Summary - Numis, Panmure Call Vectura A Buy

Vectura Gains European Approval For Once-Daily Dual Bronchodilator

Vectura Chairman To Retire After 12 Years At Helm

Broker Rating Changes Summary - SocGen Raises GKN To Buy